Source: Scientific Reports. Unidades: ICB, FM
Subjects: MICROBIOLOGIA, HEMODINÂMICA, LEUCÓCITOS, INSUFICIÊNCIA RENAL CRÔNICA, ANTINEOPLÁSICOS, NEFROPATIAS, RATOS WISTAR, ÓXIDO NÍTRICO, HIPERTENSÃO, SISTEMA RENINA-ANGIOTENSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FANELLI, Camilla et al. Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis. Scientific Reports, v. 13, n. 1, p. 18 , 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-39299-9. Acesso em: 12 maio 2024.APA
Fanelli, C., Francini, A. L. R., Celestrino, G. A., Teles, F., Barbosa, A. P., Paloma Noda,, et al. (2023). Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis. Scientific Reports, 13( 1), 18 . doi:10.1038/s41598-023-39299-9NLM
Fanelli C, Francini ALR, Celestrino GA, Teles F, Barbosa AP, Paloma Noda, Iannuzzi LR, Ornellas FM, Noronha I de L, Guzzo CR. Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis [Internet]. Scientific Reports. 2023 ; 13( 1): 18 .[citado 2024 maio 12 ] Available from: https://doi.org/10.1038/s41598-023-39299-9Vancouver
Fanelli C, Francini ALR, Celestrino GA, Teles F, Barbosa AP, Paloma Noda, Iannuzzi LR, Ornellas FM, Noronha I de L, Guzzo CR. Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis [Internet]. Scientific Reports. 2023 ; 13( 1): 18 .[citado 2024 maio 12 ] Available from: https://doi.org/10.1038/s41598-023-39299-9